vascular disease

This Week in PLOS

In PLOS this week: PHACTR1 variant linked to fibromuscular dysplasia, harbor porpoise population study, and more.

A team of researchers from  Brigham and Women's Hospital and Harvard Medical School found that the two proteins appear to have opposing effects.

According to the company, the study, which was presented at the 42nd Annual Meeting on Women's Cancer of the Society of Gynecological Oncologists, examined more than 20 candidate biomarkers, identifying three potentially useful analytes.

The NHGRI-led program has seen its first major success by identifying the genetic basis for a rare and debilitating vascular disorder.

NHLBI in late January put out an RFP for the program, which calls for researchers to develop proteomics technologies and apply them to solve clinical puzzles. It is set to begin early next year, shortly after its current two major proteomics initiatives expire.

IP Update

Premium

USPTO Publishes Six RNAi-Related Patent Applications

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.